How the Foundation Works
n-Lorem is focused on creating individual treatments for patients in the United States with nano-rare diseases caused by genetic mutations that affect approximately <30 patients in the world. Diseases or conditions with broader patient populations are likely more suitable for treatment by other non-profit or for-profit entities, which we encourage you to explore with your physician.
With a seasoned leadership team and strategic partnerships, the n-Lorem Foundation provides the framework, funds and access for nano-rare patients who are amendable to our technology to receive experimental Antisense oligonucleotides (ASOs) for free, for life.